These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 35122116)

  • 1. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome.
    Knight JS; Kanthi Y
    Semin Immunopathol; 2022 May; 44(3):347-362. PubMed ID: 35122116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?
    Siddique S; Risse J; Canaud G; Zuily S
    Curr Rheumatol Rep; 2017 Sep; 19(10):64. PubMed ID: 28871481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting thromboinflammation in antiphospholipid syndrome.
    Salet DM; Bekkering S; Middeldorp S; van den Hoogen LL
    J Thromb Haemost; 2023 Apr; 21(4):744-757. PubMed ID: 36696191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome.
    Álvarez D; Morales-Prieto DM; Cadavid ÁP
    Autoimmun Rev; 2023 Apr; 22(4):103274. PubMed ID: 36649876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.
    Meng H; Yalavarthi S; Kanthi Y; Mazza LF; Elfline MA; Luke CE; Pinsky DJ; Henke PK; Knight JS
    Arthritis Rheumatol; 2017 Mar; 69(3):655-667. PubMed ID: 27696751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pathogenesis, diagnosis and treatment of antiphospholipid syndrome].
    Ohmura K; Oku K; Atsumi T
    Nihon Rinsho; 2014 Jul; 72(7):1309-13. PubMed ID: 25163327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome.
    Grossi C; Capitani N; Benagiano M; Baldari CT; Della Bella C; Macor P; Tedesco F; Borghi MO; Maugeri N; D'Elios MM; Meroni PL
    Front Immunol; 2022; 13():1076167. PubMed ID: 36700193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.
    Yalavarthi S; Gould TJ; Rao AN; Mazza LF; Morris AE; Núñez-Álvarez C; Hernández-Ramírez D; Bockenstedt PL; Liaw PC; Cabral AR; Knight JS
    Arthritis Rheumatol; 2015 Nov; 67(11):2990-3003. PubMed ID: 26097119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
    Wang X; Gkrouzman E; Andrade DCO; Andreoli L; Barbhaiya M; Belmont HM; Branch DW; de Jesús GR; Efthymiou M; Ríos-Garcés R; Gerosa M; El Hasbani G; Knight J; Meroni PL; Pazzola G; Petri M; Rand J; Salmon J; Tektonidou M; Tincani A; Uthman IW; Zuily S; Zuo Y; Lockshin M; Cohen H; Erkan D;
    Lupus; 2021 Dec; 30(14):2276-2285. PubMed ID: 34915764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management.
    Knight JS; Branch DW; Ortel TL
    BMJ; 2023 Feb; 380():e069717. PubMed ID: 36849186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms.
    D'Ippolito S; Barbaro G; Paciullo C; Tersigni C; Scambia G; Di Simone N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on inflammation in antiphospholipid syndrome.
    Ambati A; Zuo Y; Knight JS
    Curr Opin Rheumatol; 2023 Mar; 35(2):89-97. PubMed ID: 36580355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
    Kato M; Hisada R; Atsumi T
    Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Plasma-Derived Small Extracellular Vesicles Indicates Ongoing Endothelial and Platelet Activation in Patients with Thrombotic Antiphospholipid Syndrome.
    Štok U; Blokar E; Lenassi M; Holcar M; Frank-Bertoncelj M; Erman A; Resnik N; Sodin-Šemrl S; Čučnik S; Pirkmajer KP; Ambrožič A; Žigon P
    Cells; 2020 May; 9(5):. PubMed ID: 32414170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.
    Rosina S; Chighizola CB; Ravelli A; Cimaz R
    Curr Rheumatol Rep; 2021 Jan; 23(2):10. PubMed ID: 33511497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.
    Zhang J; Li C; Han X; Chen Z; Adhikari BK; Wang Y; Wang Y; Sun J
    Ann Med; 2021 Dec; 53(1):1328-1339. PubMed ID: 34409894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome.
    Mazetto BM; Hounkpe BW; da Silva Saraiva S; Vieira-Damiani G; Dos Santos APR; Jacinto BC; Vaz CO; Mesquita GTV; Annichino-Bizzacchi JM; De Paula EV; Orsi FA
    Thromb Res; 2022 Jun; 214():132-137. PubMed ID: 35561448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibody-activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome.
    Lu Y; Dong Y; Zhang Y; Shen D; Wang X; Ge R; Zhang M; Xia Y; Wang X
    J Cell Mol Med; 2020 Jun; 24(12):6690-6703. PubMed ID: 32369873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.